These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 16519664)

  • 1. The opioid peptide nociceptin/orphanin FQ mediates prostaglandin E2-induced allodynia, tactile pain associated with nerve injury.
    Okuda-Ashitaka E; Minami T; Matsumura S; Takeshima H; Reinscheid RK; Civelli O; Ito S
    Eur J Neurosci; 2006 Feb; 23(4):995-1004. PubMed ID: 16519664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of nociceptin/orphanin FQ-induced pain responses by the novel receptor antagonist N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl) benzamide monohydrochloride.
    Muratani T; Minami T; Enomoto U; Sakai M; Okuda-Ashitaka E; Kiyokane K; Mori H; Ito S
    J Pharmacol Exp Ther; 2002 Oct; 303(1):424-30. PubMed ID: 12235279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder.
    Zhang Y; Simpson-Durand CD; Standifer KM
    Br J Pharmacol; 2015 Jan; 172(2):571-82. PubMed ID: 24666365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of neuropathic pain by the nociceptin/orphanin FQ antagonist JTC-801 is mediated by inhibition of nitric oxide production.
    Mabuchi T; Matsumura S; Okuda-Ashitaka E; Kitano T; Kojima H; Nagano T; Minami T; Ito S
    Eur J Neurosci; 2003 Apr; 17(7):1384-92. PubMed ID: 12713641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
    Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of nociceptin/orphanin FQ and NOP receptors in the response to acute and repeated restraint stress in rats.
    Delaney G; Dawe KL; Hogan R; Hunjan T; Roper J; Hazell G; Lolait SJ; Fulford AJ
    J Neuroendocrinol; 2012 Dec; 24(12):1527-41. PubMed ID: 22835008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal sensitivity to acute pain, but increased inflammatory hyperalgesia in mice lacking the nociceptin precursor polypeptide or the nociceptin receptor.
    Depner UB; Reinscheid RK; Takeshima H; Brune K; Zeilhofer HU
    Eur J Neurosci; 2003 Jun; 17(11):2381-7. PubMed ID: 12814369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of nociceptin/orphanin FQ and its receptor in electroacupuncture-produced anti-hyperalgesia in rats with peripheral inflammation.
    Fu X; Wang YQ; Wu GC
    Brain Res; 2006 Mar; 1078(1):212-8. PubMed ID: 16563360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-allodynic and anti-hyperalgesic effects of nociceptin receptor antagonist, JTC-801, in rats after spinal nerve injury and inflammation.
    Tamai H; Sawamura S; Takeda K; Orii R; Hanaoka K
    Eur J Pharmacol; 2005 Mar; 510(3):223-8. PubMed ID: 15763246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: pharmacological and genetic evidences.
    Rizzi A; Nazzaro C; Marzola GG; Zucchini S; Trapella C; Guerrini R; Zeilhofer HU; Regoli D; Calo' G
    Pain; 2006 Sep; 124(1-2):100-8. PubMed ID: 16697109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ: behavioral and electrophysiological studies in mice.
    Nazzaro C; Rizzi A; Salvadori S; Guerrini R; Regoli D; Zeilhofer HU; Calo G
    Peptides; 2007 Mar; 28(3):663-9. PubMed ID: 17161885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal administration of low-dose nociceptin/orphanin FQ induces allodynia via c-Jun N-terminal kinase and monocyte chemoattractant protein-1.
    Kawabata K; Nishimura I; Fujiwara T; Terauchi S; Minami T; Ito S; Okuda-Ashitaka E
    Eur J Neurosci; 2016 Jun; 43(11):1499-508. PubMed ID: 27038234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of NMDA receptor in nociceptive effects elicited by intrathecal [Tyr6] gamma2-MSH(6-12), and the interaction with nociceptin/orphanin FQ in pain modulation in mice.
    Chang M; Li W; Peng YL; Gao YH; Yao J; Han RW; Wang R
    Brain Res; 2009 May; 1271():36-48. PubMed ID: 19332041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of proinflammatory cytokines gene expression by nociceptin/orphanin FQ in the spinal cord and the cultured astrocytes.
    Fu X; Zhu ZH; Wang YQ; Wu GC
    Neuroscience; 2007 Jan; 144(1):275-85. PubMed ID: 17069983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats.
    Leggett JD; Harbuz MS; Jessop DS; Fulford AJ
    Neuroscience; 2006 Sep; 141(4):2051-7. PubMed ID: 16784820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intrathecally administered nociceptin/orphanin FQ in monkeys: behavioral and mass spectrometric studies.
    Ko MC; Wei H; Woods JH; Kennedy RT
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1257-64. PubMed ID: 16766718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the distribution of spinal NOP receptors in a chronic pain model using NOP-eGFP knock-in mice.
    Ozawa A; Brunori G; Cippitelli A; Toll N; Schoch J; Kieffer BL; Toll L
    Br J Pharmacol; 2018 Jul; 175(13):2662-2675. PubMed ID: 29582417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats.
    Micheli L; Di Cesare Mannelli L; Guerrini R; Trapella C; Zanardelli M; Ciccocioppo R; Rizzi A; Ghelardini C; Calò G
    Eur J Pharmacol; 2015 May; 754():73-81. PubMed ID: 25704616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior.
    Marti M; Mela F; Veronesi C; Guerrini R; Salvadori S; Federici M; Mercuri NB; Rizzi A; Franchi G; Beani L; Bianchi C; Morari M
    J Neurosci; 2004 Jul; 24(30):6659-66. PubMed ID: 15282268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of spinally administered bifunctional nociceptin/orphanin FQ peptide receptor/μ-opioid receptor ligands in mouse models of neuropathic and inflammatory pain.
    Sukhtankar DD; Zaveri NT; Husbands SM; Ko MC
    J Pharmacol Exp Ther; 2013 Jul; 346(1):11-22. PubMed ID: 23652222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.